• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,983.18 64.42
( 0.09%)
Global Indices
Nasdaq
49,934.70 -958.41
(-1.88%)
Dow Jones
7,287.94 -119.71
(-1.62%)
Hang Seng
64,234.22 -1,182.41
(-1.81%)
Nikkei 225
10,254.58 27.25
(0.27%)
Forex
USD-INR
95.53 0.30
(0.32%)
EUR-INR
110.14 0.47
(0.43%)
GBP-INR
127.43 0.45
(0.36%)
JPY-INR
0.60 0.00
(0.41%)

EQUITY - MARKET SCREENER

Accent Microcell Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
92465
INE0Q5D01013
114.8396308
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
ACCENTMIC
25.22
1105.77
EPS(TTM)
Face Value()
Div & Yield %
18.28
10
0.22
 

kapston services limited
BEML bags $36.38 million export order from Middle East
Apr 13,2026
The equipment will be deployed for infrastructure development applications, the company said in a regulatory filing.

With this order, BEML’s total international order book has reached approximately $106.95 million.

The development underscores the company’s growing presence in overseas markets and strengthens its position in the global infrastructure equipment segment.

BEML is a multi-technology ‘Schedule A’ company under the Ministry of Defence, operating across three verticals—defence & aerospace, mining & construction, and rail & metro. As of 31 March 2026, the Government of India held a 54.03% stake in the company.

The company reported a consolidated net loss of Rs 22.38 crore in Q3 FY26, compared with a net profit of Rs 24.41 crore in Q3 FY25. Revenue from operations increased 23.69% year-on-year to Rs 1,083.27 crore for the quarter ended 31 December 2025.

Shares of BEML rose 0.78% to end at Rs 1,632.80 on the BSE.